INmune Bio Inc.

NASDAQ: INMB · Real-Time Price · USD
2.53
0.08 (3.27%)
At close: Aug 15, 2025, 3:59 PM
2.47
-2.37%
After-hours: Aug 15, 2025, 07:51 PM EDT

INmune Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
20.92M 35.85M 52.15M 74.81M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
79K 131K 99K 99K
Receivables
1.41M 2.44M 8.46M 5.5M
Inventory
n/a n/a 34K -5.5M
Other Current Assets
331K n/a -34K 5.5M
Total Current Assets
22.66M 39.94M 64.67M 82.61M
Property-Plant & Equipment
307K 414K 507K 726K
Goodwill & Intangibles
16.51M 16.51M 16.51M 16.51M
Total Long-Term Assets
16.9M 17.06M 17.12M 17.34M
Total Assets
39.56M 57M 81.8M 99.94M
Account Payables
6.56M 7.9M 5.21M 3.8M
Deferred Revenue
n/a n/a 616K 474K
Short-Term Debt
n/a 9.92M 5M 72K
Other Current Liabilities
517K 524K 9K -62K
Total Current Liabilities
7.22M 18.46M 10.92M 4.36M
Long-Term Debt
n/a n/a 9.7M 14.46M
Other Long-Term Liabilities
n/a n/a 550K 199K
Total Long-Term Liabilities
244K 397K 10.77M 15.36M
Total Liabilities
7.46M 18.86M 21.69M 19.72M
Total Debt
384K 10.44M 15.31M 15.23M
Common Stock
22K 817K 18K 18K
Retained Earnings
-163.1M -121.02M -91.01M -63.72M
Comprehensive Income
-575K -799K -699K 1K
Shareholders Equity
32.1M 38.14M 60.1M 80.22M
Total Investments
n/a n/a n/a n/a